Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1. - Wikidata - awgldk - TriplyDB

Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.

Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.

http://www.wikidata.org/entity/Q36399179

about

Gamma-herpesvirus latency requires T cell evasion during episome maintenance Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients Immune regulation of human herpesviruses and its implications for human transplantation The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma Allelic polymorphism in the T cell receptor and its impact on immune responses T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display.The synthesis of truncated polypeptides for immune surveillance and viral evasion.Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism.CD8+ T-cell recognition of human cytomegalovirus latency-associated determinant pUL138.Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders Burkitt lymphoma: pathogenesis and immune evasion.Monofunctional and polyfunctional CD8+ T cell responses to human herpesvirus 8 lytic and latency proteins.G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation.mRNA Structural constraints on EBNA1 synthesis impact on in vivo antigen presentation and early priming of CD8+ T cells.Messenger RNA sequence rather than protein sequence determines the level of self-synthesis and antigen presentation of the EBV-encoded antigen, EBNA1.Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer.Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers.Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.Epstein-barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target.Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes.Technology insight: Applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies.CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1 Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition.Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses.Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis.Immunotherapies for Hodgkin's lymphoma.An HLA-A2-restricted T-cell epitope mapped to the BNLF2a immune evasion protein of Epstein-Barr virus that inhibits TAP.Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma Gly-Ala repeats induce position- and substrate-specific regulation of 26 S proteasome-dependent partial processing Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities Phosphorylation sites of Epstein-Barr virus EBNA1 regulate its function Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer.Prospects of a novel vaccination strategy for human gamma-herpesviruses.Immunotherapy for EBV-associated malignancies.Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands.Natural and adoptive T-cell immunity against herpes family viruses after allogeneic hematopoietic stem cell transplantation.

P2860

Q24803420-7C211077-654E-4B66-9365-88F927F068C9 Q26823898-F8D33D21-9C83-43A4-A85D-5E3B22AA784B Q26992146-34A19269-AB62-4EE9-975E-16E56F5D8B8A Q26998401-08EF1C0D-A643-4575-B3C7-81C64306F88B Q27016002-BA329289-9122-4A94-A340-548091AB8E5A Q27662550-CDA5F1F2-D94C-4EED-8636-8CE150655FA5 Q33519520-A9A98B7D-B8BF-449A-9229-2B5D04652671 Q33526302-BEE1BB84-CB86-440D-8005-657505A49BDA Q33733617-9C00E2E9-2C9C-41CF-82CA-19A19267A278 Q33878986-2EC9C8BA-DA7D-4AB6-B292-87EC097E7F5F Q33891292-0CFB704E-BF4F-4CDB-976C-D511A214CCA5 Q34166602-31AADD86-9021-496D-8199-14408F2A0FA3 Q34189497-CA09FA3E-5BC8-4F2A-B753-BC416F06F83C Q34189939-6FC7E054-6E58-4BC7-9454-BEA641815C9E Q34303299-D9FB374A-63F0-4D92-9F46-3203A3FEF9D1 Q34317937-C0C34D9A-5683-49F2-90DE-85FABE2ACD61 Q34539792-37E477B5-D9BE-437E-9401-575DEF946A73 Q34658852-6B6E93A3-6F3B-47D0-AFC5-99C27A4499DC Q35121627-5612C0EC-6824-4103-83DA-0E3A7D69DCF1 Q35616090-84C0046D-6E69-4576-ADE1-AB4852A97069 Q35661383-D9E155AA-5042-4ADF-B1AD-5AA46F5BC9B6 Q35775750-D614B26C-4C0A-4308-B7FA-F68ED872DD3E Q36267161-E3790591-D5F4-4E08-A28A-097FCF0E4802 Q36303951-1365C44E-58E9-4B1F-9093-00217F1790E5 Q36399195-7A930710-699A-46D9-B55D-5D5947586E69 Q36756835-CD3E611C-30C7-498E-AF65-6D6238199CB9 Q36835091-B1512BCC-583B-4AAA-B78D-D4E8EF9AAF31 Q36943860-15521485-7A38-444C-A231-31E045FE5872 Q37006427-30C2318C-DB5D-467B-965A-7753D568163B Q37110627-8B971220-7CD1-4561-8229-36B6697394E6 Q37117769-DA574E99-A195-4A95-BC97-AA28CAC2A465 Q37142562-46A22513-14E1-497C-A5FD-01E77D35F5CF Q37319382-8E481BAD-DBF5-4ABE-94EE-2A43DC9A18EE Q37450613-33907845-8BF3-43E8-AFA1-4A11E9A609CE Q37713951-50CDB654-0E7B-467E-B20A-866A71A98D93 Q37773234-73029E06-91F3-4F7E-893A-57405D67CAFA Q37780705-11CDB42D-719C-46BF-BB4B-B6297724B4FC Q37845178-73B7586D-4845-4496-933A-F90340FCD229 Q37854496-695041BD-5439-4B8C-982D-A0E077FAD89E Q37888687-4C06EACE-7937-45E4-AC1D-1F258AEA0C77

P2860

Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.

http://www.wikidata.org/entity/Q36399179

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Endogenous presentation of CD8 ...... rus-encoded nuclear antigen 1.

@ast

Endogenous presentation of CD8 ...... rus-encoded nuclear antigen 1.

@en

type

label

Endogenous presentation of CD8 ...... rus-encoded nuclear antigen 1.

@ast

Endogenous presentation of CD8 ...... rus-encoded nuclear antigen 1.

@en

prefLabel

Endogenous presentation of CD8 ...... rus-encoded nuclear antigen 1.

@ast

Endogenous presentation of CD8 ...... rus-encoded nuclear antigen 1.

@en

P1433

Q36399179-9A166CC9-FF86-4618-8606-7E443B1B36FF

P1476

Q36399179-1BE465BC-BA38-4337-8D2C-DFBFAD7BF42B

P2093

Q36399179-1DAEA391-9748-4B03-9A82-646852C933D3

Q36399179-1F5C2D73-163E-4024-8F1D-67000190633E

Q36399179-595C75AD-D585-4702-960C-54DD7EE410DF

Q36399179-C8EFBC8D-640D-4215-888C-FC054A02828F

Q36399179-D29CF01C-F348-48D0-990A-E5668F61A8B0

Q36399179-FF00A2E4-6A80-4DE0-B197-4BAF5E8D5630

P2860

Q36399179-0E4DDA65-9465-4E2C-AE5D-28ABB1341E88

Q36399179-130D16D6-A318-4B78-A142-803E2E1F94B1

Q36399179-18132301-884C-4917-9D41-A8860C3C5E6C

Q36399179-1D84D622-91D5-484F-83E8-406F8CBF1281

Q36399179-1E90C5E9-C221-4A85-9A4B-AC6DEF6FE963

Q36399179-209EFEF0-A086-4E7B-B4E8-64627483AFBF

Q36399179-260C328D-B8E6-477D-AFBD-0839B72DBB7A

Q36399179-2848AA71-2D97-4A0D-8F4D-B98657085E8D

Q36399179-3C2883FE-2790-4841-A105-D7A862A640E8

Q36399179-3DE78536-8253-4D2A-81C5-F0601F67EA16

P304

Q36399179-28074335-785E-45D2-85C9-C8019F55EE0F

P31

Q36399179-318E3C8C-ACA9-4EF9-BEFC-5D7856301D27

P356

Q36399179-188CA85D-D0BC-4BF6-925A-9E418861CF40

P407

Q36399179-1920A2CE-C605-4372-AB14-0AFF8C32233C

P433

Q36399179-A30BD1CF-8885-4E01-ABD3-93428ACD8DB1

P478

Q36399179-4A21C947-591F-4264-9706-DBF43372FF78

P50

Q36399179-D267E2F0-ECEC-4145-AB9A-DA8F7B943FDE

P577

Q36399179-BD1B8E4B-38CB-4CE1-8AD7-F5EAC70E89B9

P5875

Q36399179-83926CD7-6070-40B3-A073-B7B494D52D1D

P698

Q36399179-3B6D4CBF-1919-4852-AF26-13A1755DD2D9

P921

Q36399179-60CFF6E7-9C64-4EA0-A2FE-321AE2D0C1A9

P932

Q36399179-EF9FB5A1-EE33-4542-9F46-453A3B111A0B

P356

P1433

Journal of Experimental Medicine

P1476

Endogenous presentation of CD8 ...... rus-encoded nuclear antigen 1.

@en

P2093

Denis J Moss

http://www.w3.org/2001/XMLSchema#string

Geoff Connolly

http://www.w3.org/2001/XMLSchema#string

Judy Tellam

http://www.w3.org/2001/XMLSchema#string

Katherine J Green

http://www.w3.org/2001/XMLSchema#string

Rajiv Khanna

http://www.w3.org/2001/XMLSchema#string

Scott R Burrows

http://www.w3.org/2001/XMLSchema#string

P2860

Cells adapted to the proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survival

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7.

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

Dissecting the host response to a gamma-herpesvirus.

Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue.

Viral subversion of the immune system.

Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases.

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?

P304

1421-1431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20040191

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

199

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8558492

http://www.w3.org/2001/XMLSchema#string

P698

15148340

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

2211806

http://www.w3.org/2001/XMLSchema#string